The U.S. Food and Drug Administration (FDA) has recently declared the recall of Philips’ respiratory machines, which includes models like Trilogy Evo, Evo O2, and EV300, as the highest level of seriousness. This classification was made due to potential risks of significant injuries or fatalities linked to their use. Philips initiated the recall on March 29, 2023 affecting approximately 73,000 units in the United States. The recall was prompted by the detection of environmental contaminants such as dust and dirt within the air pathways of certain devices, which are vital for assisting individuals with respiratory issues to maintain consistent breathing. To date, the FDA has received 542 reports concerning this problem, including two injuries and one death. The distribution of these devices spanned from March 26, 2019, to March 22, 2023.
CPAP is 'most effective' for controlling blood pressure in sleep apnea patients "The HeartBEAT Study" finds that continuous positive airway Read more
Want a good night's sleep? Quit smoking As if cancer, heart disease and other diseases were not enough motivation to make quitting smoking your New Read more
Sleep Apnea May Boost Risk of Sudden Cardiac Death Sleep apnea raises the risk of sudden cardiac death, according to Read more
Sleep Therapy Seen as an Aid for Depression Curing insomnia in people with depression could double their chance of a Read more
Losing just half an hour of sleep 'can impact body weight and metabolism' The findings of new research presented at Read more
Attention Problems May Be Sleep-Related Diagnoses of attention hyperactivity disorder among children have increased dramatically in recent years, rising 22 percent from Read more
